February 28, 2017
FDA: Avella recalling injectable products labeled ‘latex free’
Editor's Note
The Food and Drug Administration (FDA) on February 24 announced that Avella Specialty Pharmacy of Houston is recalling all unexpired sterile injectable products labeled “latex free” that were produced at Advanced Pharma’s Houston location between September 1, 2016 and February 16, 2017.
Avella and Advanced Pharma have been unable to confirm whether its “latex free” label statements are accurate in all cases.
Risk of potential adverse events can range from local site reactions including swelling and inflammation, to allergic reactions which could be life-threatening to users who are sensitive to latex.
Read More >>
Free Daily News
- Session: Keep calm and recover—Essential service recovery tools for new OR leaders
- Session: Bridge the gap—Finding a common mission between the OR and SPD
- Session: Supporting a successful transition from clinician to leader
- Session: Overcoming imposter syndrome to master performance conversations
- Opening keynote: Healthcare's 'Blockbuster Moment'—Innovation, Disruption, and the Future of Nursing
- Session: Using 16th century Samurai code to help leaders succeed
- Workshop: Mastering The Joint Commission standards and CMS regulations
- Workshop: The leadership shift—From managing tasks to leading with influence
- Simulation-based robotic surgery training boosts team confidence, communication
- Perioperative leaders gather at 2025 OR Manager Conference
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement